Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Colorcon
AstraZeneca
Chubb
Medtronic
Queensland Health
US Department of Justice
Chinese Patent Office
US Army

Generated: June 22, 2018

DrugPatentWatch Database Preview

ROWASA Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Rowasa, and what generic alternatives are available?

Rowasa is a drug marketed by Mylan Speciality Lp and Meda Pharms and is included in two NDAs.

The generic ingredient in ROWASA is mesalamine. There are twenty-eight drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
Drug patent expirations by year for ROWASA
Pharmacology for ROWASA
Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Medical Subject Heading (MeSH) Categories for ROWASA
Synonyms for ROWASA
1764-EP2272825A2
1764-EP2275420A1
2-Hydroxy-5-aminobenzoic acid
24215-EP2289518A1
24215-EP2295053A1
24215-EP2295409A1
24215-EP2314574A1
24215-EP2314590A1
3-amino-6-hydroxybenzoic acid
3-carboxy-4-hydroxyaniline
35589-28-7 (mono-hydrochloride salt)
3amino-6-hydroxybenzoic acid
4-14-00-02058 (Beilstein Handbook Reference)
4Q81I59GXC
5 Aminosalicylate
5 Aminosalicylic Acid
5-?Aminosalicylic Acid (Mesalazine)
5-Amino Salicylic Acid
5-amino-2-hydroxy-benzoic acid
5-Amino-2-hydroxybenzoic acid
5-Amino-2-hydroxybenzoic acid 97%
5-Amino-2-hydroxybenzoic acid; 5-AS; Mesalamine; 5-ASA
5-amino-2-hydroxybenzoicacid
5-amino-salicylic acid
5-Aminosalicyclic acid
5-Aminosalicylate
5-Aminosalicylic acid
5-Aminosalicylic acid, >=99%
5-Aminosalicylic acid, 95%
5-Aminosalicylic acid, analytical standard
5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine
5-Aminosalicylic Acid, Purified
5-Aminosalicylic acid, tablet
5-Aminosalicylicacid
5-AS
5-ASA
61513-32-4
6291-36-7 (hydrochloride)
89-57-6
90701-EP2371811A2
A0317
A3613/0153179
AB00374979
AB00374979_11
AB00374979_12
AB00374979-09
AB00374979-10
AB1001921
AC-2764
AC1L1HCS
AC1Q51L9
ACMC-1BKFR
ACN-S002469
AI3-15564
AJ-08068
AJG-501
AK-72925
AKOS000118959
Allphar Brand of Mesalamine
AM20060091
AN-874
Antigen Brand of Mesalamine
ANW-39326
Apriso
Apriso (TN)
ARONIS23914
Asacol
Asacol (TN)
Asacol HD
Asacolitin
Asacolon
Asalit
Ascolitin
Axcan Brand of Mesalamine
BB_NC-0015
BBL013046
BCP9000175
BDBM60918
Benzoic acid, 5-amino-2-hydroxy-
BIDD:GT0811
BP-13074
BPBio1_001164
BR-72925
BRN 2090421
BSPBio_001058
Byk Brand of Mesalamine
Canasa
Canasa (TN)
CAS-89-57-6
CCG-100829
CCRIS 7334
Celltech Brand of Mesalamine
CHEBI:6775
CHEMBL704
cid_4075
Claversal
cMAP_000045
CPD000145728
CS-2219
CTK3E8105
D00377
D0C4YC
DB00244
Delzicol
Delzicol (TN)
DSSTox_CID_4506
DSSTox_GSID_24506
DSSTox_RID_77435
DTXSID5024506
EC 201-919-1
EINECS 201-919-1
F1918-0003
Falk Brand of Mesalamine
Farmasa Brand of Mesalamine
FC1035
Ferring Brand of Mesalamine
Fisalamine
Fivasa
FT-0619950
GlaxoSmithKline Brand of Mesalamine
GTPL2700
Henning Berlin Brand of Mesalamine
HMS1571E20
HMS2051M21
HMS2090I09
HMS2098E20
HMS3393M21
HMS3649K15
HMS3651M15
HS-0100
HSDB 7512
HY-15027
Hydrochloride, Mesalamine
I06-0488
Iialda
Iialda (TN)
InChI=1/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11
Ipocal (TN)
Ipocol
KB-196569
KB-196728
KBio2_002425
KBio2_004993
KBio2_007561
KBio3_002904
KBioGR_002425
KBioSS_002431
KBOPZPXVLCULAV-UHFFFAOYSA-N
KS-00000CC5
KS-000048PQ
KSC448C0L
Lialda
Lialda (TN)
Lixacol
LS-1894
LS11426
m Aminosalicylic Acid
M-7246
m-Aminosalicylic acid
Masacol (TN)
MAX-002
MCULE-5752745805
MD-0901
Merckle Brand of Mesalamine
Mesacol
mesalamine
Mesalamine (Lialda)
Mesalamine (TN)
mesalamine (USAN)
Mesalamine (USP)
Mesalamine [USAN:USP]
Mesalamine [USAN]
Mesalamine HCl
Mesalamine Monosodium Salt
Mesalamine, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Mesalamine, United States Pharmacopeia (USP) Reference Standard
Mesalamine|||Mesalazine
Mesalazina
Mesalazina [Spanish]
Mesalazina[Spanish]
Mesalazine
Mesalazine (JAN/INN)
Mesalazine [INN]
Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard
Mesalazine MMX
Mesalazine, European Pharmacopoeia (EP) Reference Standard
Mesalazinum
Mesalazinum [Latin]
mesalsal
Mesasal
Mesavance
Mesavancol
meta Aminosalicylic Acid
meta-Aminosalicylic Acid
Meta-AminosalicylicAcid
Mezavant
Mezavant XL
MFCD00007877
minosalicylic acid
MLS000758287
MLS001424012
MolPort-001-641-024
Monosodium Salt, Mesalamine
NC00079
NCGC00016344-01
NCGC00016344-02
NCGC00016344-03
NCGC00016344-04
NCGC00016344-05
NCGC00016344-07
NCGC00090934-01
NCGC00090934-02
NCGC00257142-01
NCGC00259159-01
Norgine Brand of Mesalamine
Novo 5 ASA
Novo-5 ASA
Novo5 ASA
Novopharm Brand of Mesalamine
NSC 38877
NSC-38877
NSC-759301
NSC38877
NSC759301
Oprea1_847633
OR011141
OR174775
p-Aminosalicylsaeure
p-Aminosalicylsaeure [German]
Pentacol
Pentasa
Pentasa (TN)
Pharmakon1600-01505993
Prestwick0_001069
Prestwick1_001069
Prestwick2_001069
Prestwick3_001069
Procter & Gamble Brand of Mesalamine
Provalis Brand of Mesalamine
PubChem17623
Q-201355
Rowasa (TN)
RP21708
RTR-032941
s1681
SALICYLIC ACID, 5-AMINO-
Salicylic acid, 5-amino-(8CI)
Salofalk
Salofalk (TN)
Salofalk Granu-Stix
Salozinal
SAM001247020
Sanofi Synthelabo Brand of Mesalamine
SBB052617
SC-15695
SCHEMBL31297
Schering Plough Brand of Mesalamine
Schering-Plough Brand of Mesalamine
sfRowasa
Sfrowasa (TN)
SmithKline Brand of Mesalamine
SMR000145728
Solvay Brand of Mesalamine
SPBio_002969
SPD 476
SPD-476
SPD-480
SR-01000763486
SR-01000763486-9
ST2411704
ST4109571
STK301678
Tox21_110384
Tox21_110384_1
Tox21_201610
Tox21_303125
TR-032941
TRA0073805
UNII-4Q81I59GXC
WLN: ZR DQ CVQ
Yamanouchi Brand of Mesalamine
Z-206
Z57127471
ZINC1688

US Patents and Regulatory Information for ROWASA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp ROWASA mesalamine ENEMA;RECTAL 019618-001 Dec 24, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Meda Pharms ROWASA mesalamine SUPPOSITORY;RECTAL 019919-001 Dec 18, 1990 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ROWASA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp ROWASA mesalamine ENEMA;RECTAL 019618-001 Dec 24, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp ROWASA mesalamine ENEMA;RECTAL 019618-001 Dec 24, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cerilliant
Healthtrust
Queensland Health
Medtronic
Deloitte
Accenture
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.